- Home
- NTRS vs DXCM Comparison
NTRS vs DXCM Comparison
Compare NTRS & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NTRS | DXCM |
|---|---|---|
| Founded | 1889 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.5B | 26.5B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | NTRS | DXCM |
|---|---|---|
| Price | $140.86 | $66.32 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 21 |
| Target Price | ★ $144.69 | $85.00 |
| AVG Volume (30 Days) | 967.9K | ★ 4.1M |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 2.32% | N/A |
| EPS Growth | N/A | ★ 47.18 |
| EPS | N/A | ★ 2.09 |
| Revenue | N/A | N/A |
| Revenue This Year | $8.13 | $14.48 |
| Revenue Next Year | $4.27 | $12.39 |
| P/E Ratio | ★ $16.88 | $32.47 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $81.62 | $54.11 |
| 52 Week High | $157.60 | $89.07 |
Technical Indicators
Market Signals| Indicator | NTRS | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 43.74 | 33.85 |
| Support Level | $139.24 | $63.19 |
| Resistance Level | $141.25 | $69.38 |
| Average True Range (ATR) | 4.19 | 1.78 |
| MACD | -0.71 | -0.79 |
| Stochastic Oscillator | 39.78 | 9.13 |
Price Performance
Historical ComparisonAbout NTRS Northern Trust Corporation
Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of December 2024, Northern Trust had assets under custody or administration of $16.8 trillion and assets under management of $1.6 trillion.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.